Neurocompute Narrative Velocity Map
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative
Velocity Map

Explore the Parkinson’s research intelligence diagram before entering the Neurocompute platform.

NC
Neurocompute
AI Parkinson’s Intelligence Terminal
RESEARCH PAPER

ZPT01, a herbal formula of Zingiberis Rhizoma, Paeoniae Radix and Tribuli Fructus, protects dopaminergic neurons and suppresses neuroinflammation in a Parkinson's disease model.

PMID
41944913
Journal
Molecular biology reports
Publication Date
2026-04-07
Grade
B

AI Summary

ZPT01, a three‑herb formulation, improved motor behavior and protected dopaminergic neurons in MPTP mice and, supported by docking and cell experiments, appears to act via restoring AKT phosphorylation and suppressing COX‑2/PTGS2‑mediated neuroinflammation.

Why It Matters

This work provides preclinical evidence of a multi‑target neuroprotective and anti‑inflammatory candidate that engages translationally relevant pathways (AKT signaling and COX‑2) for PD, making it a promising starting point for further pharmacology, PK/PD, and safety studies despite the usual…

Abstract

BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss and chronic neuroinflammation for which effective disease-modifying treatments remain limited. Increasing evidence suggests that herbal extracts can modulate multiple pathological pathways involved in PD. In this study, we developed a novel herbal formulation, ZPT01, and investigated its therapeutic potential using an integrated approach combining in vivo, in vitro, and in silico analyses. METHODS AND RESULTS: In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models, ZPT01 administration improved motor symptoms, protected dopaminergic neurons, and alleviated neuroinflammatory responses. Network pharmacology analysis identified AKT serine/threonine kinase 1 (AKT1) and prostaglandin-endoperoxide synthase 2 (PTGS2) as key molecular targets, and subsequent molecular docking demonstrated a strong binding affinity between the active compounds and these targets. In vitro experiments further validated these findings, showing that ZPT01 restored the phosphorylation of AKT, a protein product of the AKT1 gene, in 1-methyl-4-phenylpyridinium-exposed PC12 cells and suppressed cyclooxygenase-2 (the protein encoded by PTGS2) expression in lipopolysaccharide-stimulated BV2 microglia. CONCLUSIONS: Our study highlights the neuroprotective and anti-inflammatory properties of ZPT01 and provides promising evidence for its potential as a therapeutic candidate for PD.

Score Breakdown

AI Score
76.0
Base Score
78.6
Rank Score
74.3
Narrative Velocity
-
AI Confidence
-
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic
Full Neurocompute Infographic